Socrus Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 32.01 Cr
as on 16-12-2024
- Paid Up Capital ₹ 32.00 Cr
as on 16-12-2024
- Company Age 35 Year, 1 Month
- Last Filing with ROC 31 Mar 2010
About Socrus Bio Sciences
The Corporate was formerly known as Shreeji Analytical Lab Pvt Ltd. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 32.01 Cr and a paid-up capital of Rs 32.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhvi Agnihotri, Rajeev Agnihotri, Sanjay Upadhyay, and Two other members serve as directors at the Company.
- CIN/LLPIN
U99999MH1989PLC054030
- Company No.
054030
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Oct 1989
- Date of AGM
29 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Socrus Bio Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Agnihotri  | Managing Director | 26-Nov-2007 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhvi Agnihotri | Director | 18-Dec-2007 | Current |
| Sanjay Upadhyay | Additional Director | 07-Jul-2009 | Current |
| Sunil Jain | Additional Director | 07-Jul-2009 | Current |
| Manish Jain | Additional Director | 07-Jul-2009 | Current |
Financial Performance and Corporate Structure Insights of Socrus Bio Sciences.
Enhance accessibility to Socrus Bio Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Socrus Bio Sciences?
Unlock access to Socrus Bio Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Socrus Pharmaceuticals LimitedActive 38 years 10 monthsMadhvi Agnihotri, Rajeev Agnihotri and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Socrus Bio Sciences?
Unlock and access historical data on people associated with Socrus Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Socrus Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Socrus Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
